DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» MOG antibody disease
MOG antibody disease
Consensus Statement on Immune Modulation in Multiple Sclerosis
SERIES #3 Mlet's Gaoin Gmentum a Collaborative Series Brought to You by the Sumaira Foundation for NMO and the MOG Project ACUTE VS
Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody
MOG Antibody Positive Optic Perineuritis: an Observational Study in Han Chinese
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease
Full Disclosures
Biomarkers in Rare Demyelinating Disease of the Central Nervous System
Neuromyelitis Optica Spectrum Disorders
Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
CNS Inflammatory Vasculopathy with Antimyelin Oligodendrocyte Glycoprotein Antibodies in COVID-19
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights Into the Disease Pathophysiology, Diagnosis and Management
Neuromyelitis Optica Spectrum Disorders
Steroid-Resistant Double-Seronegative Optic Neuritis Responds Favorably to Plasma Exchange
Myths & Truths About COVID-19 Vaccines and MS
Latin American Consensus Recommendations for Management
Clinical Presentation and Diagnosis of Multiple Sclerosis
Pain in NMOSD and MOGAD: a Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies
Autoimmune Encephalitis: Clinical Spectrum and Management
Top View
Post–COVID-19 Acute Disseminated Encephalomyelitis in a 17-Month-Old Loren A
Accepted for Publication in Journal of Neuro-Ophthalmology
CASE REPORT 26-Year-Old Woman
P-00814 (12/2020) 4
Update on AQP4 Channelopathy and MOG Opathy
Neuromyelitis Optica Spectrum Disorders That Have No Antibodies to Aquaporin-4
Multiple Sclerosis and Related Disorders 26 (2018) 37–39
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
The Transverse Myelitis Association 'Ask the Expert' Podcast Series
Characterization of the Human Myelin Oligodendrocyte Glycoprotein Antibody Response in Demyelination Fiona Tea1,2, Joseph A
Serum Peptide Immunoglobulin G Autoantibody Response in Patients with Different Central Nervous System Inflammatory Demyelinating Disorders
The Current Role of MRI in Differentiating Multiple Sclerosis from Its Imaging Mimics Abstract
Complementary and Alternative Therapies
Neurimminfl2018018622 1..3
Targeting B Cells to Modify MS, NMOSD, and MOGAD Part 2
Free Thyroxine Level Is Associated with Both Relapse Rate and Poor
Abstracts of the 51St Annual Conference of the Italian Society of Neurology
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders
Clinical Course, Therapeutic Responses and Outcomes in Relapsing MOG Antibody-Associated Demyelination
CSF Cytokine Profile in MOG-Igg+ Neurological Disease Is Similar To
Neurological Update: MOG Antibody Disease
MOG Encephalomyelitis: International Recommendations on Diagnosis and Antibody Testing S
Understanding Clinical Trial Results for NMOSD
B Cell Depletion Therapies in Autoimmune Disease: Advances and Mechanistic Insights
Targeting B Cells to Modify MS, NMOSD, and MOGAD Part 1
Myelin Oligodendrocyte Glycoprotein and Neuromyelitis Optica/Aquaporin-4 Antibody Negative COVID-19-Associated Optic Neuritis
First Report of Coexistence of MOG-Antibody-Positive Disease And
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Related Disease
Clinical Outcomes of Transverse Myelitis with Myelin